BioMark Diagnostics Inc., providing universal access to cancer diagnostics and early stage detection by leveraging the power of new technology.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Screening tests and diagnostic procedures for some cancers dropped off sharply during the first COVID-19
Elizabeth PaynePublishing date:Feb 04, 2021 Fewer Canadians have been diagnosed with cancer during the COVID-19
World Cancer Day every 4 February is the global uniting initiative led by the Union for International Cancer Control (UICC).
BY MORGAN LOWRIE, THE CANADIAN PRESS Posted Feb 4, 2021 10:24 am PST MONTREAL, Italy —
A rapid COVID-19 saliva test could be used wherever crowds gatherMaria Rantanen / Richmond News A
An amazing show of public support for UBC disease researcher Dr. Horciao Bach, who has
4 February 2020 News release Geneva, Switzerland The World Health Organization (WHO) today spells out the need
Vancouver, British Columbia – (August 19th, 2019) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE:
MAY 31, 2019 — Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Rashid A. Bux (CEO)
info@biomarkdiagnostics.com